BlueLinx (BXC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Delivered solid Q4 and full-year 2024 results despite high mortgage rates and record home prices, with net sales of $3.0 billion and adjusted EBITDA of $131 million.
Specialty products comprised 70% of net sales and 80% of gross profit for both Q4 and full year, maintaining strong gross margins.
Digital transformation initiatives advanced, including master data management, e-commerce, and a new transportation management system.
Launched first greenfield location in Portland, Oregon, with more planned and limited capex per site.
Liquidity remained robust at $852 million, including $506 million in cash at year-end.
Financial highlights
Q4 2024 net sales were $711 million, flat year-over-year; specialty sales down 1%, structural sales up 1%.
Q4 gross profit was $113 million, gross margin 15.9%; net income $5.3 million, EPS $0.62.
Q4 adjusted EBITDA was $22 million (3% of net sales); adjusted net income $5.2 million, adjusted EPS $0.61.
Full-year net sales were $3.0 billion, down 5.9% from 2023; adjusted EBITDA $131 million (4.4% margin).
Full-year adjusted net income was $55 million, adjusted EPS $6.44; gross margin 16.6%.
Outlook and guidance
Early Q1 2025: specialty product gross margin 18–19%, structural product gross margin 8–9%; daily sales volumes down low double digits due to severe weather.
2025 SG&A expected to increase slightly as a percentage of sales due to technology and growth investments.
2025 capital investments expected around $40 million, focused on facilities, fleet, and technology.
Tax rate for 2025 anticipated in the 24%-28% range.
Single-family housing starts expected to be flat to down in 2025; repair and remodel market projected to improve slightly.
Latest events from BlueLinx
- Flat sales, specialty growth, and strong liquidity amid market headwinds and margin pressure.BXC
Q4 202525 Feb 2026 - Q2 2024 net sales fell 5.8%-6%, but specialty margins and liquidity remained strong.BXC
Q2 20242 Feb 2026 - Net sales fell 7.7%-8%, but strong cash flow and liquidity supported capital returns.BXC
Q3 202417 Jan 2026 - Director elections, auditor ratification, and executive pay are key 2025 meeting agenda items.BXC
Proxy Filing1 Dec 2025 - Q1 2025 net sales fell 2.3% as margins compressed, but liquidity and repurchases stayed strong.BXC
Q1 202528 Nov 2025 - Q2 2025 sales rose 2%, but net income and margins declined amid higher costs and price deflation.BXC
Q2 202516 Nov 2025 - Q3 sales up 0.2%, margins down, specialty leads, Disdero deal, and strong liquidity.BXC
Q3 202513 Nov 2025